| Product Code: ETC9681285 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Circulating Tumor DNA (ctDNA) Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Circulating Tumor DNA (ctDNA) Market - Industry Life Cycle |
3.4 Thailand Circulating Tumor DNA (ctDNA) Market - Porter's Five Forces |
3.5 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.7 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Thailand Circulating Tumor DNA (ctDNA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Advancements in technology for ctdna analysis |
4.2.3 Growing awareness and adoption of personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 High cost associated with ctdna testing |
4.3.2 Limited reimbursement policies for ctdna testing in Thailand |
4.3.3 Lack of standardized protocols for ctdna analysis |
5 Thailand Circulating Tumor DNA (ctDNA) Market Trends |
6 Thailand Circulating Tumor DNA (ctDNA) Market, By Types |
6.1 Thailand Circulating Tumor DNA (ctDNA) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Routine Screening, 2021- 2031F |
6.1.4 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Patient Work Up, 2021- 2031F |
6.1.5 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Early-Stage Disease, 2021- 2031F |
6.1.6 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Late Stage/Metastatic Disease, 2021- 2031F |
6.2 Thailand Circulating Tumor DNA (ctDNA) Market, By Sample |
6.2.1 Overview and Analysis |
6.2.2 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Urine, 2021- 2031F |
6.2.4 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Circulating Tumor DNA (ctDNA) Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Sample Preparation, 2021- 2031F |
6.3.3 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Ultra-Low Passage Whole Genome Sequencing,, 2021- 2031F |
6.3.4 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By ctDNA Quantification, 2021- 2031F |
6.3.5 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Copy Number Analysis, 2021- 2031F |
6.3.6 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Statistical Analysis, 2021- 2031F |
6.4 Thailand Circulating Tumor DNA (ctDNA) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.4 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Academia, 2021- 2031F |
6.4.5 Thailand Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Thailand Circulating Tumor DNA (ctDNA) Market Import-Export Trade Statistics |
7.1 Thailand Circulating Tumor DNA (ctDNA) Market Export to Major Countries |
7.2 Thailand Circulating Tumor DNA (ctDNA) Market Imports from Major Countries |
8 Thailand Circulating Tumor DNA (ctDNA) Market Key Performance Indicators |
8.1 Number of research collaborations between healthcare institutions and technology companies for ctdna analysis |
8.2 Percentage increase in the number of ctdna tests conducted annually in Thailand |
8.3 Adoption rate of ctdna testing by oncologists in major healthcare facilities |
9 Thailand Circulating Tumor DNA (ctDNA) Market - Opportunity Assessment |
9.1 Thailand Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Thailand Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.3 Thailand Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 Thailand Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Thailand Circulating Tumor DNA (ctDNA) Market - Competitive Landscape |
10.1 Thailand Circulating Tumor DNA (ctDNA) Market Revenue Share, By Companies, 2024 |
10.2 Thailand Circulating Tumor DNA (ctDNA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here